🇺🇸 FDA
Patent

US 10845366

Predictive markers for polyamine inhibitor cancer therapies

granted A61KA61K31/192A61K31/196

Quick answer

US patent 10845366 (Predictive markers for polyamine inhibitor cancer therapies) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/192, A61K31/196, A61K31/198, A61K31/616